Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07798232 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Penicillin to Prevent Early Rheumatic Heart Disease in School-Aged Children

Study acronym: MEERCATS 2
StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Secondary endpoints: 7 to 9
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will look at whether children ages 5-8 who take Penicillin V by mouth twice a day are less likely to develop rheumatic heart disease (RHD) over a 3-year period compared to children who do not take the medicine.
Trial Details
NCT Number NCT07798232
Lead Sponsor Children's Hospital Medical Center, Cincinnati
Collaborators: The University of Western Australia, Uganda Heart Institute, Ochsner Health System, Murdoch Childrens Research Institute
Conditions Rheumatic Heart Disease in Children
Enrollment 9,622 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov